Berger B, Doucet G, Descarries L
INSERM U106, Bâtiment de Pédiatrie, Hôpital de la Salpêtrière, Paris, France.
Brain Res. 1988 Feb 16;441(1-2):260-8. doi: 10.1016/0006-8993(88)91404-7.
An in vitro radioautographic approach was used to count dopamine axon terminals (varicosities) of the mediofrontal and the supragenual cingulate cortex in 30-40-day-old rats treated with 6-hydroxydopamine at birth or with N(2-chloro-ethyl)N-ethyl-2-bromobenzylamine hydrochloride (DSP-4) 7-10 days earlier. Compared to controls, there were no increases in the density of dopamine innervation in either region of the noradrenaline-denervated cortex after either treatment. The results, therefore, did not support the hypothesis of a sprouting of dopamine terminals reported to account for augmented cortical dopamine levels under these conditions. In line with earlier observations, such biochemical changes might rather be indicative of altered dopamine steady-state levels.
采用体外放射自显影方法,对出生时用6-羟基多巴胺处理或7-10天前用盐酸N-(2-氯乙基)-N-乙基-2-溴苄胺(DSP-4)处理的30-40日龄大鼠的中额叶和膝上扣带回皮质的多巴胺轴突终末(膨体)进行计数。与对照组相比,两种处理后去甲肾上腺素失神经支配皮质的任一区域中多巴胺神经支配密度均未增加。因此,这些结果不支持在这些条件下据报道可解释皮质多巴胺水平升高的多巴胺终末发芽假说。与早期观察结果一致,这种生化变化可能更表明多巴胺稳态水平发生了改变。